{"success":true,"data":{"pressRelease":{"id":"147681","rtpr_id":"nPn4d0xWMa-20260918","ticker":"AEMD","exchange":"NASDAQ","all_tickers":["AEMD"],"title":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)","author":"PR Newswire","published_at":"2026-09-18T18:00:00.239Z","article_body":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)\nPR Newswire\n\nNEW YORK, Sept. 18, 2026\n\nNEW YORK, Sept. 18, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=3693151749&u=https%3A%2F%2Fmonteverdelaw.com%2Fjuan-e-monteverde%2F&a=Juan+Monteverde)\nwith Monteverde & Associates PC\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=3742038177&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=Monteverde+%26+Associates+PC)\n (the \"M&A Class Action Firm\"), has recovered millions of dollars for\nshareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities\nClass Action Services Report. The firm is headquartered at the Empire State\nBuilding in New York City and is investigating Aethlon Medical, Inc. (NASDAQ:\nAEMD\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=2262656045&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FAEMD%2F&a=AEMD)\n) related to its merger with North Immunology, Inc. Under the terms of the\nproposed transaction, Upon closing of the proposed transaction, Aethlon\nshareholders will own approximately 4.75% of the combined company. Is it a\nfair deal?\n\nClick here for more info https://monteverdelaw.com/case/aethlon-medical-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=623780134&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Faethlon-medical-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Faethlon-medical-inc%2F)\n. It is free and there is no cost or obligation to you.\n\nNOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a\nlawyer and ask:\n\n1. Do you file class actions and go to Court?\n2. When was the last time you recovered money for shareholders?\n3. What cases did you recover money in and how much?\n\nAbout Monteverde & Associates PC\n\nOur firm litigates and has recovered money for shareholders...and we do it\nfrom our offices in the Empire State Building. We are a national class action\nsecurities firm with a successful track record in trial and appellate courts,\nincluding the U.S. Supreme Court.\n\nNo one is above the law. If you own common stock in the above listed company\nand have concerns or wish to obtain additional information free of charge,\nplease visit our website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=91299480&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=website)\n or contact Juan Monteverde, Esq. either via e-mail at\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)  or by\ntelephone at (212) 971-1341.\n\nContact:\nJuan Monteverde, Esq.\nMONTEVERDE & ASSOCIATES PC\nThe Empire State Building\n350 Fifth Ave. Suite 4740\nNew York, NY 10118\nUnited States of America\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)\nTel: (212) 971-1341\n\nAttorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm\nresponsible for this advertisement is Monteverde & Associates PC\n(www.monteverdelaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=2651844084&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=www.monteverdelaw.com)\n). Prior results do not guarantee a similar outcome with respect to any future\nmatter.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-aethlon-medical-inc-nasdaq-aemd-302883442.html\n(https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-aethlon-medical-inc-nasdaq-aemd-302883442.html)\n\nSOURCE Monteverde & Associates PC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS753151/Monteverde-Associates-PC-Logo.jpg?id=OA2957807\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn4d0xWMa-20260918","title":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)","author":"PR Newswire","ticker":"AEMD","created":"2026-09-18T18:00:00.239Z","tickers":["AEMD"],"exchange":"NASDAQ","article_body":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)\nPR Newswire\n\nNEW YORK, Sept. 18, 2026\n\nNEW YORK, Sept. 18, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=3693151749&u=https%3A%2F%2Fmonteverdelaw.com%2Fjuan-e-monteverde%2F&a=Juan+Monteverde)\nwith Monteverde & Associates PC\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=3742038177&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=Monteverde+%26+Associates+PC)\n (the \"M&A Class Action Firm\"), has recovered millions of dollars for\nshareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities\nClass Action Services Report. The firm is headquartered at the Empire State\nBuilding in New York City and is investigating Aethlon Medical, Inc. (NASDAQ:\nAEMD\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=2262656045&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FAEMD%2F&a=AEMD)\n) related to its merger with North Immunology, Inc. Under the terms of the\nproposed transaction, Upon closing of the proposed transaction, Aethlon\nshareholders will own approximately 4.75% of the combined company. Is it a\nfair deal?\n\nClick here for more info https://monteverdelaw.com/case/aethlon-medical-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=623780134&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Faethlon-medical-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Faethlon-medical-inc%2F)\n. It is free and there is no cost or obligation to you.\n\nNOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a\nlawyer and ask:\n\n1. Do you file class actions and go to Court?\n2. When was the last time you recovered money for shareholders?\n3. What cases did you recover money in and how much?\n\nAbout Monteverde & Associates PC\n\nOur firm litigates and has recovered money for shareholders...and we do it\nfrom our offices in the Empire State Building. We are a national class action\nsecurities firm with a successful track record in trial and appellate courts,\nincluding the U.S. Supreme Court.\n\nNo one is above the law. If you own common stock in the above listed company\nand have concerns or wish to obtain additional information free of charge,\nplease visit our website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=91299480&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=website)\n or contact Juan Monteverde, Esq. either via e-mail at\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)  or by\ntelephone at (212) 971-1341.\n\nContact:\nJuan Monteverde, Esq.\nMONTEVERDE & ASSOCIATES PC\nThe Empire State Building\n350 Fifth Ave. Suite 4740\nNew York, NY 10118\nUnited States of America\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)\nTel: (212) 971-1341\n\nAttorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm\nresponsible for this advertisement is Monteverde & Associates PC\n(www.monteverdelaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4777832-1&h=2651844084&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=www.monteverdelaw.com)\n). Prior results do not guarantee a similar outcome with respect to any future\nmatter.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-aethlon-medical-inc-nasdaq-aemd-302883442.html\n(https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-aethlon-medical-inc-nasdaq-aemd-302883442.html)\n\nSOURCE Monteverde & Associates PC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS753151/Monteverde-Associates-PC-Logo.jpg?id=OA2957807\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-18T18:00:00.277185958Z","server_sent_at_ms":1789754400277},"received_at":"2026-09-18T18:00:00.332Z","source_url":"https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-aethlon-medical-inc-nasdaq-aemd-302883442.html"},"analysis":{"id":"136483","press_release_id":"147681","analysis_json":{"industry":{"label":"Medical Devices","sector":"Health Care"},"redFlags":["Proposed merger would leave Aethlon shareholders with only ~4.75% of the combined company -- heavily dilutive structure worth monitoring","Law-firm solicitation, not issuer disclosure -- no new company information"],"eventType":"legal_litigation","narrative":"Monteverde & Associates PC, the self-described 'M&A Class Action Firm,' announced an investigation of Aethlon Medical (NASDAQ: AEMD) related to its proposed merger with North Immunology, Inc.\n\nThe firm is questioning deal fairness because, upon closing, shareholders will own approximately 4.75% of the combined company.\n\nThe release is attorney advertising from a plaintiff law firm soliciting shareholder contacts at no cost, not a disclosure from Aethlon itself; no claim has been filed and no class certified, so treat as low-signal noise despite the underlying merger context.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress; only notable datum is the ~4.75% pro forma ownership for AEMD holders in the North Immunology merger."},"keyFigures":{"customDimensions":{"aethlon_pro_forma_ownership_pct":"approximately 4.75%"}},"quotedText":"shareholders will own approximately 4.75% of the combined company","namedEntities":{"people":[{"name":"Juan Monteverde","role":"Class Action Attorney, Monteverde & Associates PC"}],"products":[],"companies":[{"name":"Monteverde & Associates PC","relationship":"plaintiff law firm / release author"},{"name":"Aethlon Medical, Inc.","ticker":"AEMD","relationship":"investigation target"},{"name":"North Immunology, Inc.","relationship":"merger counterparty"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Monteverde & Associates PC (explicitly labeled Attorney Advertising, SOURCE is the law firm). No issuer disclosure, no filed claim, no certified class or settlement -- merely an 'investigation' of the North Immunology merger terms to solicit shareholder contacts."},"tickerRelevance":{"others":[],"primary":"AEMD"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"law-firm-solicitation","hasSettlement":false,"issuerAuthored":false,"underlyingEventNote":"references pending merger with North Immunology; investigation only","hasClassCertification":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Monteverde & Associates PC, the self-described 'M&A Class Action Firm,' announced an investigation of Aethlon Medical (NASDAQ: AEMD) related to its proposed merger with North Immunology, Inc.\n\nThe firm is questioning deal fairness because, upon closing, shareholders will own approximately 4.75% of the combined company.\n\nThe release is attorney advertising from a plaintiff law firm soliciting shareholder contacts at no cost, not a disclosure from Aethlon itself; no claim has been filed and no class certified, so treat as low-signal noise despite the underlying merger context.","key_figures":{"customDimensions":{"aethlon_pro_forma_ownership_pct":"approximately 4.75%"}},"named_entities":{"people":[{"name":"Juan Monteverde","role":"Class Action Attorney, Monteverde & Associates PC"}],"products":[],"companies":[{"name":"Monteverde & Associates PC","relationship":"plaintiff law firm / release author"},{"name":"Aethlon Medical, Inc.","ticker":"AEMD","relationship":"investigation target"},{"name":"North Immunology, Inc.","relationship":"merger counterparty"}],"dollarAmounts":[]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-18T18:00:28.027Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"micro-cap","eventGravity":"law-firm-solicitation","hasSettlement":false,"issuerAuthored":false,"underlyingEventNote":"references pending merger with North Immunology; investigation only","hasClassCertification":false}},"durationMs":27701,"modelName":"glm-5.3-flash"}}